Joseph Young, MD
Adult Reconstructive Orthopaedic Surgery · Falmouth, MENPI 1225569627
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Smith+Nephew at 50.3% of the total. Reporting peaked in 2023 at $10,257 and has fallen 89.1% since, to $1,120 in 2025.
Across 88 payments — averaging $183.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Zimmer Biomet$6K
- Stryker$1K
- Medacta USA, Inc.$611
- Johnson & Johnson$124
- Bone Support Inc.$116
What the payments were for
- Travel & lodging$4,40427%
- Food & beverage$3,46021%
- Education$8,24751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $8,108 |
| Zimmer Biomet | 54 | $5,771 |
| Stryker | 21 | $1,381 |
| Medacta USA, Inc. | 7 | $611 |
| Johnson & Johnson | 1 | $124 |
| Bone Support Inc. | 1 | $116 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult reconstructive orthopaedic surgery providers in Maineto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 20 | $136 |
| Meloxicam | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Falmouth
- Brian McGroryFalmouth$424K
- Michael RobertsFalmouth$56K
- Justin KuetherFalmouth$10K
- Donald EndrizziFalmouth$107
- Michael BeckerFalmouth$90
- Stephen WalshBangor$745K
- Zafar AhmadLewiston$14K
- Michael DefranceAuburn$8K
- Megan RichardsBangor$4K
- Brigham McKenneySouth Portland$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.